You are here

Article info

Article menu
Download PDFPDF
Therapeutics/Prevention
Randomised controlled trial
Angiotensin receptor-neprilysin inhibitors in heart failure: a shifting paradigm

Authors

  1. Correspondence to : Professor Orly Vardeny, Department of Pharmacy, University of Wisconsin-Madison, 777 Highland Avenue, Madison, WI 53705-2222, USA; orly.vardeny{at}wisc.edu
View Full Text

Citation

Vardeny O
Angiotensin receptor-neprilysin inhibitors in heart failure: a shifting paradigm
BMJ Evidence-Based Medicine 2015;20:61.

Publication history

  • First published February 6, 2015.
Online issue publication 
March 14, 2024

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions